Mataram – BRIN Public Relations. Two flagship products of the National Research and Innovation Agency (BRIN) in the health sector were displayed at the NTB INOVTEK EXPO 2022 event held at the Regional Research and Innovation Agency (BRIDA) Office of West Nusa Tenggara (NTB) province, which takes place from 18 – 20 March 2022. The two products are ventilators to assist patients in breathing and radiopharmaceuticals with its product, Samarium ETDMP.

Ventilator is a breathing apparatus which is much needed during the pandemic in many hospitals to help Covid-19 patients who experience breathing problems due to being infected with Covid-19 virus. Development of ventilators by BRIN is a form of research concern in Indonesia for the condition that many people need this device during the pandemic.

Ironically, most of the breathing apparatus circulating in Indonesia are imported products. This condition is further complicated by the very limited number of ventilators available in various hospitals.

For that reason, since March 2020 BRIN has worked hard to make ventilators in the hope of overcoming the limited number of ventilators in hospitals. Researcher at the Electronics Research Center, Dena Kurnianto Wibowo, said production of these ventilators is carried out in marathon works, and it took three months to get certification from the Health Facility Safety Center.

“In only three months, we had obtained certification from the Health Facility Safety Center and also distribution permit from the Ministry of Health,” said Dena.

“Collaboration with a State-Owned Enterprise (BUMN), PT. LEN Industri is the key to speedy completion of ventilator production. With the ability to manufacture ventilators domestically, the price of the product can compete with foreign products, even cheaper than the prices of imported products,” he asserted.

Other products on display were Samarium 153 ETDMP, a drug for cancer palliative therapy. This therapy aims to reduce the pain felt by cancer patients, especially those that have metastasized to the bone.

“By prescribing Samarium 153 ETDMP, the patient’s pain can be reduced and can improve the life quality of cancer patients,” said Researcher at the Center for Radiopharmaceutical and Biodosimetry Radioisotope Technology, Amal Rezka Putra.

Thus far, cancer patients are given morphine to reduce the pain, but this method has a negative effect, namely addiction.While, by using Samarium 153 ETDMP, patients are only injected once a month, some even up to two months, and there is no addictive effect.

Therefore, said Amal, prescribing Samarium 153 ETDMP to cancer patients, they will no longer feel pain so they can do activities like normal people. This product has received a distribution permit from the Food and Drug Supervisory Agency in 2016.

As up to now, Amal explained, 15 hospitals have used Samarium 153 ETDMP, one of which has routinely used this product, namely Dr. Karyadi Hospital in Semarang.

A visitor who is interested in these two products, Umi Kulsum said that she is proud that Indonesia has been able to produce health products that are very beneficial for the community. “This is very encouraging and can be an alternative for cancer patients in particular, with less severe effects,” said Umi.

Umi admitted that she had never known before that Indonesia had been able to produce such a drug to treat cancer. What Umi knows all this time is that only chemotherapy is used to treat cancer.

According to Umi, this exhibition is very important and can be used as an event to disseminate research products, considering that there are still many people who do not know the results of BRIN’s research. “I hope that BRIN continues to disseminate its research products to the public, so that many people understand more and that product research is also more widespread in the community,” concluded Umi. (pur)